Substituted triazole derivatives and uses thereof

US11230540B2 · kind B2 · utility

Assignee

• Bayer Pharma Aktiengesellschaft · DE

Inventors

• Marie-Pierre Collin-Kroepelin · Wuppertal, DE
• Peter Kolkhof · Wuppertal, DE
• Thomas Neubauer · Wuppertal, DE
• Chantal Fuerstner · Neheim, DE
• Elisabeth Pook · Wuppertal, DE
• Hanna Tinel · Wuppertal, DE
• Carsten Schmeck · Wuppertal, DE
• Pierre Wasnaire · Mülheim an der Ruhr, DE
• Heiko Schirmer · Solingen, DE
• Klemens Lustig · Wuppertal, DE

Key dates

• Filing date: Oct 17, 2018
• Grant date: Jan 25, 2022
• Expiry date: Oct 17, 2038

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel substituted 1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of renal and cardiovascular diseases.